BNP Paribas’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.6M Buy
71,695
+1,939
+3% +$1.05M 1.1% 21
2025
Q4
$40.5M Buy
69,756
+5,799
+9% +$3.28M 1.16% 20
2025
Q3
$30M Sell
63,957
-718
-1% -$334K 0.9% 29
2025
Q2
$26.3M Buy
64,675
+5,825
+10% +$2.44M 0.85% 32
2025
Q1
$29.3M Buy
58,850
+7,295
+14% +$3.95M 1.22% 23
2024
Q4
$26.8M Buy
51,555
+5,556
+12% +$3.05M 0.16% 29
2024
Q3
$28.4M Buy
45,999
+740
+2% +$438K 1.18% 26
2024
Q2
$24.9M Sell
45,259
-579
-1% -$332K 1.25% 25
2024
Q1
$26.4M Buy
+45,838
New +$25.7M 1.23% 25

Other funds holding TMO

BNP Paribas's TMO Position: Q1 2026 in Review

BNP Paribas increased its Thermo Fisher Scientific (TMO) stake by 2.8% in Q1 2026, buying an estimated $1.05M and bringing the position to 71,695 shares worth $34.6M. The position accounts for 1.1% of the portfolio, ranked #21.

BNP Paribas first reported a position in TMO in Q1 2024 and has held it in 9 quarters since. The position peaked at $40.5M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • BNP Paribas held 71,695 shares of Thermo Fisher Scientific worth $34.6M as of Q1 2026.
  • BNP Paribas bought 1,939 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.05M.
  • Thermo Fisher Scientific made up 1.1% of BNP Paribas's portfolio in Q1 2026, its #21 holding.
  • BNP Paribas first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 9 quarters since.
  • BNP Paribas's Thermo Fisher Scientific position peaked at $40.5M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.